Amgen
AMGN
3,264 hedge funds and large institutions have $185B invested in Amgen in 2026 Q3 according to their latest regulatory filings, with 270 funds opening new positions, 1,239 increasing their positions, 1,264 reducing their positions, and 106 closing their positions.
155% more first-time investments, than exits
New positions opened: 270 | Existing positions closed: 106
49% more funds holding in top 10
Funds holding in top 10: 55 → 82 (+27)
3% more funds holding
Funds holding: 3,179 → 3,264 (+85)
2% less repeat investments, than reductions
Existing positions increased: 1,239 | Existing positions reduced: 1,264
2.32% less ownership
Funds ownership: 83.64% → 81.32% (-2.3%)
20% less call options, than puts
Call options by funds: $2.42B | Put options by funds: $3.02B
29% less capital inflows, than outflows
Capital inflows: $8.27B | Capital outflows: $11.6B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.28B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$617M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$426M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$354M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$278M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.92B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$779M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$441M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$435M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$418M |
AMGN Hedge Fund Activity: Q3 2026 in Review
3,264 of the 8,212 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2026, worth a combined $185B — up 13% from $163B a quarter earlier.
Buyers outnumbered sellers: 270 funds opened new AMGN positions and 106 closed out — a net gain of 164 holders — while 1,239 added to existing stakes and 1,264 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $1.28B. The largest seller was Royal Bank of Canada, cutting an estimated $1.92B.
- 3,264 institutional investors held Amgen (AMGN) as of Q3 2026, up from 3,179 in Q2 2026.
- Funds reported $185B of Amgen stock for Q3 2026, up 13% quarter-over-quarter.
- 270 funds opened new Amgen positions in Q3 2026 and 106 closed out, a net change of +164 holders.
- The largest Amgen buyer in Q3 2026 was JP Morgan Chase, an estimated $1.28B added.
- The largest Amgen seller in Q3 2026 was Royal Bank of Canada, an estimated $1.92B sold.
Based on aggregated 13F filings for Q3 2026.